StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.08+0.07 (+2.33%)

Close on Nov 17, 2026Market cap $175.59MP/E –Yield –

Whitehawk Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Whitehawk Therapeutics's operating margin for the twelve months ending Dec 31, 2025 was -1601.1%. For fiscal 2025 it was -1601.1%, against -259.6% the year before. The highest annual figure on record is -18.2% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1601.1%−1341.5
FY2024Dec 31, 2024-259.6%+35.7
FY2023Dec 31, 2023-295.4%+116.6
FY2022Dec 31, 2022-411.9%+382.5
FY2021Dec 31, 2021-794.4%−776.2
FY2020Dec 31, 2020-18.2%+37.3
FY2018Dec 31, 2018-55.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 2025-213.0%+151.5
Q4 FY2024Dec 31, 2024-261.8%+18.3
Q3 FY2024Sep 30, 2024-186.0%+113.5
Q2 FY2024Jun 30, 2024-252.2%+62.9
Q1 FY2024Mar 31, 2024-364.5%−77.7
Q4 FY2023Dec 31, 2023-280.0%+16.0
Q3 FY2023Sep 30, 2023-299.5%+54.7
Q2 FY2023Jun 30, 2023-315.1%+219.0
Q1 FY2023Mar 31, 2023-286.8%+312.0
Q4 FY2022Dec 31, 2022-296.0%−181.1
Q3 FY2022Sep 30, 2022-354.2%+3051.6
Q2 FY2022Jun 30, 2022-534.2%−596.1
Q1 FY2022Mar 31, 2022-598.8%+554.0
Q4 FY2021Dec 31, 2021-114.9%−176.6
Q1 FY2021Mar 31, 2021-3405.8%+410128.6
Q4 FY2020Dec 31, 202061.9%+2.4
Q3 FY2020Sep 30, 2020-1152.8%−700.1
Q2 FY2020Jun 30, 202061.7%–
Q4 FY2018Dec 31, 2018-413534.4%–
Q3 FY2018Sep 30, 201859.5%–
Q2 FY2018Jun 30, 2018-452.7%–

More Whitehawk Therapeutics figures

See a number that looks wrong?